Can cadmium exposure dysregulate immune function and amplify inflammatory signaling?

Cadmium is a toxic metal with biologically credible effects on redox balance and immune regulation. The evidence supports cellular and signaling disruption, while clinical claims about infection or autoimmune disease amplification remain mechanistically plausible rather than established.

Immune and inflammatory effects

• Cadmium can alter macrophage behavior, including lipopolysaccharide-triggered NF-κB signaling in primary human macrophages and pro-inflammatory macrophage polarization in animal models. Effects extend to NK, T, and B cells and antibody-related function, but can be suppressive or activating depending on dose, duration, lineage, and concurrent immune stimulus.
• In a large cross-sectional U.S. analysis, each doubling of urinary cadmium was associated with 41 fewer circulating lymphocytes/µL. This supports an association with altered immune-cell profiles but does not demonstrate impaired immune function or causality.

Oxidative-stress mechanisms

• The strongest evidence concerns oxidative stress. Cadmium binds cellular thiols, depletes glutathione, impairs antioxidant defenses, and disrupts mitochondria, increasing reactive oxygen species despite not being redox-active itself.
• This redox disruption can activate NF-κB/AP-1 and cytokine pathways. In experimental lung and Kupffer-cell models, antioxidant treatment, ROS scavenging, or blockade of NF-κB nuclear translocation reduced cadmium-associated inflammatory responses.
• Human biomonitoring is concordant: urinary cadmium has been associated with higher 8-oxodG, an oxidative DNA-damage marker, and with higher CRP in adjusted population analyses.

Host defense and inflammatory amplification

• Altered phagocytosis, bacterial-stimulus responses, NK-cell activity, and lymphocyte/antibody function provide a coherent basis for dysregulated host defense.
• These same pathways make amplification of pathogen-associated or autoimmune inflammation plausible, but neither infection risk, vaccine-response impairment, nor autoimmune inflammatory progression has been established prospectively in humans.

Bottom line

• Cadmium credibly promotes oxidative stress and can dysregulate immune and inflammatory signaling; it is a plausible—but not clinically proven—amplifier of infection-related or autoimmune inflammation.